Low T Drug Lawsuit Funding Available Now

Whitney Taylor | June 16th, 2014

Low T Drug Lawsuit FundingLawsuits involving serious side effects associated with testosterone therapy drugs have now been centralized in federal court. Multidistrict litigation has been established in U.S. District Court for the Northern District of Illinois in order to streamline early trial proceedings for a growing number of cases.

Despite coordination efforts, plaintiffs who have filed these lawsuits may find low T drug lawsuit funding can help them stay afloat financially as the lengthy legal process runs its course.

MDL transfer signed

The United States Judicial Panel on Multidistrict Litigation signed the initial transfer order on June 6, transferring at least 45 cases involving testosterone drugs from various manufacturers. The majority of lawsuits involve AndroGel, a topical testosterone therapy by Abbott. Other products involved in the MDL include AndroDerm, Axiron, Foresta, Testim and Depo-Testosterone. Although some proposals wanted to limit the MDL to AndroGel products, the judicial panel determined the coordination would be better served by including other manufacturers as well.

All of the products included in the MDL have been linked to serious cardiovascular injury, including blood clots, heart attacks and strokes. Some of the men who have suffered these side effects have died from their injuries, while others have incurred extensive medical expenses and lost wages to treat and manage their conditions. The men involved in these lawsuits claim the makers of the testosterone drugs failed to provide adequate warning about the risks associated with their products.

About testosterone therapy

Testosterone replacement therapy or TRT has been prescribed for many years to men who suffer from abnormally low testosterone levels – a medical condition known as hypogonadism. More recently, the drugs have been prescribed to men over the age of 40 who suffer symptoms associated with low testosterone or low T, such as fatigue, loss of libido and mood swings. However, reports of serious side effects linked to these drugs is now making some medical professionals question the decision to prescribe these products to men who do not have an actual medical condition.

In November 2013, a study was published in the Journal of the American Medical Association, linking testosterone therapy to a higher risk of heart attacks for men with a history of cardiovascular disease. The drug has also been linked to a higher incidence of cardiovascular injury in men over the age of 65, regardless of medical history. In January 2014, the FDA announced it was investigating the risk of heart attack, stroke and death for men taking testosterone therapy.

Low T lawsuits on the rise

Now, men are filing lawsuits against the manufacturers of these products, claiming they were unaware of the risks when they were prescribed these drugs for low testosterone levels. The initial 45 cases in the MDL are expected to grow exponentially in coming months, with plaintiffs currently involved in the litigation predicting the number could get into the thousands. As more lawsuits are added to the coordination, the time it will take to work through early trial proceedings could be extended. At this time, there is no way of knowing when early trials in the MDL, known as bellwether trials, might be scheduled.

While they are in legal limbo, plaintiffs may be dealing with ongoing medical bills. Some may find themselves in a financial crunch due to time off work while they were injured, resulting in lost wages. Although the legal process may be moving forward, it may be months or even years before plaintiffs see any jury awards or settlement negotiations to provide financial relief.

For some of these plaintiffs facing financial strain, low T drug lawsuit funding may help cover the bills until cases finally make it to trial or see a settlement. An industry leader in lawsuit loans like LawStreet Capital can ensure you get the money you need now, without waiting for the legal process to run its course. Cash advances can be made on jury awards or projected settlements that might be expected in the future quickly and easily.

Advantages of a testosterone therapy lawsuit loan

A testosterone therapy lawsuit loan is a non-recourse cash advance based on what a plaintiff might be expected to receive on his case. The application process takes just a few minutes and approval can be given nearly right away. Once the funding is approved, cash can be placed in your account within 24 hours, for you to use as you need as your case continues. No money is due until you receive a settlement or jury award and if no money is recovered, you are under no obligation to pay back the advance.

LawStreet Capital can help you wait out the results of your lawsuit without worry over how you will pay the bills throughout the legal process. To learn more about our funding options, or to begin your application process, contact a LawStreet Capital customer representative anytime at 1.866.FUND.662.